Cargando…
Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
The epidemiology of Clostridium difficile infections (CDI) has evolved during the last decades, with an increase in the reported incidence, severity of cases, and rate of mortality and relapses. These increases have primarily affected some special populations including the elderly, patients requirin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702225/ https://www.ncbi.nlm.nih.gov/pubmed/23843696 http://dx.doi.org/10.2147/IDR.S24434 |